|
Market Closed -
Nasdaq
01:30:00 30/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 15.58 USD | +3.32% |
|
-5.63% | -14.21% |
| 21/09 | Avalo Therapeutics, Inc.(NasdaqCM:AVTX) added to S&P Global BMI Index | CI |
| 20/08 | Avalo Therapeutics Insider Sold Shares Worth $1,450,419, According to a Recent SEC Filing | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.32% | -5.63% | -20.47% | -19.23% | -14.21% | +19.66% | -46.22% | -99.76% | -99.88% | 84Cr | |
| -0.70% | -4.28% | +2.07% | +27.34% | +77.25% | +52.62% | +86.42% | +7.04% | - | 7.15TCr | |
| +0.14% | +1.58% | -3.04% | +4.63% | +18.44% | +37.56% | +81.80% | +227.17% | +5,449.02% | 6.01TCr | |
| +4.77% | +6.16% | +14.76% | +61.99% | +78.28% | +36.77% | +26.10% | -55.69% | - | 2.8TCr | |
| -1.73% | -4.30% | -2.45% | +10.40% | -33.56% | -18.37% | +357.94% | +340.83% | +729.48% | 2.53TCr | |
| -0.51% | -2.28% | -3.43% | +4.57% | +3.54% | +0.48% | -9.27% | -64.47% | - | 2.48TCr | |
| +0.69% | +1.57% | +9.71% | +29.69% | +14.85% | +20.78% | -4.75% | -17.12% | +106.02% | 2.1TCr | |
| +3.46% | +3.02% | -22.65% | +4.38% | +182.04% | +158.90% | +337.81% | +1,394.96% | +639.22% | 1.55TCr | |
| +0.48% | +0.86% | +7.71% | +8.05% | +33.81% | +44.56% | +168.42% | +184.29% | +377.61% | 1.45TCr | |
| +2.96% | +0.83% | -2.05% | +11.65% | +24.17% | -5.25% | +519.59% | - | - | 1.44TCr | |
| +5.88% | -4.26% | +19.37% | +14.46% | -6.29% | -22.54% | +776.47% | +239.34% | +76.05% | 1.31TCr | |
| -1.47% | -1.81% | -4.56% | -3.38% | -12.52% | +14.97% | +248.84% | +536.56% | +4,051.92% | 1.18TCr | |
| +2.26% | +11.49% | +20.91% | +23.45% | -3.81% | -23.02% | +209.69% | +153.97% | - | 1.25TCr | |
| +1.21% | -7.81% | -21.98% | -17.70% | -0.21% | +96.12% | +146.56% | +9.27% | +807.53% | 935.81Cr | |
| -0.79% | -2.89% | -8.95% | -24.78% | +3.31% | +21.80% | +122.81% | +95.42% | +633.41% | 912.55Cr | |
| +3.64% | -4.95% | +9.69% | +0.68% | +345.96% | +243.58% | +422.49% | -8.12% | - | 935.84Cr | |
| -2.71% | -3.95% | -5.26% | -1.78% | +22.87% | +63.61% | +11.20% | +120.24% | - | 843.58Cr | |
| +3.07% | -2.16% | -4.46% | +3.77% | +7.08% | -34.22% | +103.97% | -21.81% | - | 813.14Cr | |
| -1.25% | -7.88% | -6.24% | -6.03% | +158.61% | +417.85% | +591.59% | -56.33% | -49.04% | 747.01Cr | |
| +0.25% | +3.35% | -6.55% | -0.71% | +2.02% | +0.38% | +172.02% | +276.91% | - | 712.48Cr | |
| Average | +0.65% | -1.89% | -1.39% | +6.57% | +45.08% | +56.31% | +216.17% | +171.72% | +1,156.48% | 1.86TCr | |
| Weighted average by Cap. | +0.42% | -1.68% | +0.64% | +14.31% | +44.25% | +44.18% | +173.02% | +162.53% | +2,261.14% |
- Stock Market
- Stocks
- AVTX Stock
- Sector Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
